Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/22
A61M-011/00
A61M-003/00
A61F-013/00
출원번호
US-0188325
(2002-06-27)
발명자
/ 주소
Johnson, Randolph Mellus
Theeuwes, Felix
Gillis, Edward M.
Litmanovitz, Dana
Laidlaw, Barbara
Brown, James
Culwell, John
Filice, James A.
Wickman, Peter
Yum, Su-Il
Poutiatine, Andrew
Dinka
출원인 / 주소
Durect Corporation
대리인 / 주소
Francis Carol L.
인용정보
피인용 횟수 :
87인용 특허 :
60
초록▼
The invention features devices and methods for treatment of pain. The drug delivery device is a drug delivery system adapted for whole implantation in a subject and to provide pain relief by delivery of fentanyl or a fentanyl congener (e.g., sufentanil) over a protracted period of time (e.g., at lea
The invention features devices and methods for treatment of pain. The drug delivery device is a drug delivery system adapted for whole implantation in a subject and to provide pain relief by delivery of fentanyl or a fentanyl congener (e.g., sufentanil) over a protracted period of time (e.g., at least 3 days or more than 3 days). The device comprises a housing defining a reservoir that contains a drug formulation, a pump operatively connected to the housing so as to facilitate movement of drug out of the reservoir and out of the device, and a thermal expansion element which defines a flow pathway comprising a thermal expansion channel to accommodate thermal expansion of formulation in the reservoir. The device can further comprise a valve positioned within the flow pathway so as to prevent movement of drug out of the reservoir prior to use.
대표청구항▼
1. A controlled drug delivery device, adapted for whole implantation in a subject, the device comprising:a housing defining a reservoir, the reservoir containing a formulation comprising a drug selected from the group consisting of fentanyl or a fentanyl congener, wherein the drug is present in an a
1. A controlled drug delivery device, adapted for whole implantation in a subject, the device comprising:a housing defining a reservoir, the reservoir containing a formulation comprising a drug selected from the group consisting of fentanyl or a fentanyl congener, wherein the drug is present in an amount sufficient for treatment of pain in a subject for a period of at least about 3 days;a pump operatively connected to the housing; anda thermal expansion element comprising an inlet, a thermal expansion channel adapted to contain a volume of formulation associated with thermal expansion, and an outlet;wherein in use, the inlet, thermal expansion channel, and outlet define a flow pathway from the reservoir and out of the device such that actuation of the pump effects movement of formulation through the flow pathway. 2. The device of claim 1, wherein the flow pathway of the thermal expansion element is at least partially defined by a plug seated within the housing. 3. The device of claim 1, wherein the flow pathway of the thermal expansion element is at least partially defined by a plug seated within the housing, and an inner wall of the housing. 4. The device of claim 1, wherein the thermal expansion element comprises a valve positioned and adapted for maintaining a sealed reservoir until opened. 5. The device of claim 4, wherein the thermal expansion element comprises a plunger, wherein at least a portion of the plunger is slidably positioned within the flow pathway and seated within the valve such that when in a closed position the plunger and valve occlude the flow pathway to prevent movement of formulation out of the outlet. 6. The device of claim 1, wherein the flow pathway narrows from a wider inlet and thermal expansion channel to a narrower outlet. 7. The device of claim 1, wherein the device is adapted for delivery of drug at a rate of from about 0.01 micrograms per hour to 2000 micrograms per hour. 8. The device of claim 1, wherein said drug is present in a concentration of about 5 mg/mL to about 400 mg/mL. 9. The device of claim 1, wherein the drug is sufentanil. 10. A method of treating pain in a subject, the method comprising the steps of:wholly implanting at an implantation site in a subject the drug delivery device of claim 1; andparenterally delivering the formulation from the drug delivery device to the subject so that drug enters the systemic circulation and is transported thereby to a site of action in an amount sufficient to treat pain. 11. The method of claim 10, wherein the thermal expansion element of the device comprises a valve and a plunger, at least a portion of the plunger being slidably positioned within the flow pathway and seated within the valve such that when in a closed position the plunger and valve occlude the flow pathway to prevent movement of formulation past the thermal expansion channel in a direction toward the outlet, and wherein the method further comprises the step of actuating the plunger so as to open the valve prior to said implanting. 12. The method of claim 10, wherein the drug delivery device is implanted at a subcutaneous site. 13. The method of claim 10, wherein the formulation is delivered at a volume rate of from about 0.01 μl/day to 2 ml/day. 14. The method of claim 10, wherein drug is delivered at a rate of from about 0.01 μg per hour to 2,000 μg per hour. 15. The method of claim 10, wherein the drug is sufentanil. 16. The method of claim 10, wherein said delivering is for a period of from about 4 weeks to 12 months. 17. The method of claim 10, wherein the device comprises an amount of drug sufficient to provide for alleviation of pain in the subject for a period of more than 30 days. 18. A controlled drug delivery device, adapted for whole implantation in a subject, the device comprising:a housing defining a reservoir, the reservoir containing a formulation comprising sufentanil in an amount sufficient for treatment of pain in a subject for a period of a t least about 3 days;a pump operatively connected to the housing; anda thermal expansion element comprising an inlet, a thermal expansion channel adapted to contain a volume of formulation associated with thermal expansion, and a delivery outlet;wherein in use, the inlet, thermal expansion channel, and outlet define a flow pathway from the reservoir and out of the device such that actuation of the pump effects movement of formulation through the flow pathway. 19. The device of claim 18, wherein the flow pathway of the thermal expansion element is at least partially defined by a plug seated within the housing. 20. The device of claim 18, wherein the flow pathway of the thermal expansion element is at least partially defined by a plug seated within the housing, and an inner wall of the housing. 21. The device of claim 18, wherein the thermal expansion element comprises a valve. 22. The device of claim 18, wherein the thermal expansion element comprises a plunger, wherein at least a portion of the plunger is slidably positioned within the flow pathway and seated within the valve such that when in a closed position the plunger and valve occlude the flow pathway to prevent movement of formulation through the outlet. 23. The device of claim 18, wherein said drug is present in a concentration of about 50 mg/mL to about 400 mg/mL. 24. A method of treating pain in a subject, the method comprising the steps of:wholly implanting at an implantation site in a subject the drug delivery device of claim 18; andparenterally delivering the formulation from the drug delivery device to the subject so that drug enters the systemic circulation and is transported thereby to a site of action in an amount sufficient to treat pain. 25. The method of claim 23, wherein the drug delivery device is implanted at a subcutaneous site. 26. The method of claim 23, wherein the formulation is delivered at a volume rate of from about 0.01 μl/day to 2 ml/day. 27. The method of claim 23, wherein the device comprises an amount of drug sufficient to provide for alleviation of pain in the subject for a period of more than 30 days.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (60)
Lewis John W. (North Ferriby GB2) Lloyd-Jones John G. (Cottingham GB2), Analgesic compositions.
Ackerman Eric W. (Am Nuenen NLX) Grouls Rene J. E. (Eindhoven NLX) Korsten Hendrikus H. M. (Eindhoven NLX), Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief.
Kuczynski Anthony L. ; Childers Jerry D. ; Barclay Glen E. ; Rodriguez Susan ; Merrill Sonya, Composition and dosage form comprising opioid antagonist.
Athayde Amulya L. (Mountain View CA) Faste Rolf A. (Stanford CA) Horres ; Jr. C. Russell (Del Mar CA) Low Thomas P. (La Honda CA), Controlled release osmotic pump.
Kitchell Judith P. (Newton MA) Muni Indu A. (N. Reading MA) Boyer Yvonne N. (Salem MA), Controlled, sustained release delivery system for treating drug dependency.
Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Delivery system comprising biocompatible beneficial agent formulation.
Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Perry John R. (Palo Alto CA), Delivery system for beneficial agent over a broad range of rates.
Haynes Duncan H (4051 Barbarossa Ave. Miami FL 33133) Bodeker Ben H. (3925 Dunes Way Burtonsville MD 20866) Kline Mark D. (11403 Ashley Dr. Rockville MD 20852), Drug releasing surgical implant or dressing material.
Dudley Trent O. ; Behrens Richard T. ; Zook Christopher P., Fault tolerant sync mark detector enabled relative to a frequency of an acquisition preamble for sampled amplitude recor.
Aebischer Patrick (Barrington RI) Goddard Moses (Tiverton RI) Moldauer John G. (Brooklyn NY) Mulhauser Paul J. (New York NY) Rathbun Anne M. (Providence RI) Sanberg Paul R. (Greenwich RI) Vasconcello, Implantable therapy systems and methods.
Crain Stanley M. (Leonia NJ) Shen Ke-Fei (Flushing NY), Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endoge.
Crain Stanley M. ; Shen Ke-Fei, Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists.
Crain Stanley M. (Leonia NJ) Shen Ke-fei (Flushing NY), Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other b.
Crain Stanley M. ; Shen Ke-fei, Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other b.
Crain Stanley M. ; Shen Ke-fei, Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists.
Crain Stanley M. (Leonia NJ) Shen Ke-fei (Flushing NY), Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other o.
Higuchi Takeru (Lawrence KS) Leeper Harold M. (Mountain View CA), Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient.
Rovati Luigi (Monza ITX) Makovec Francesco (Monza ITX) Senin Paolo (Monza ITX) Casula Pierluigi (Monza ITX), Proglumide, pharmaceutical preparations and compositions including it for use in human pain relief.
John R. Peery ; Keith E. Dionne ; James B. Eckenhoff ; Felix A. Landrau ; Scott D. Lautenbach ; Judy A. Magruder ; Jeremy C. Wright, Sustained delivery of an active agent using an implantable system.
Peery John R. ; Dionne Keith E. ; Eckenhoff James B. ; Landrau Felix A. ; Lautenbach Scott D. ; Magruder Judy A. ; Wright Jeremy C., Sustained delivery of an active agent using an implantable system.
Peery John R. ; Dionne Keith E. ; Eckenhoff James B. ; Landrau Felix A. ; Lautenbach Scott D. ; Magruder Judy A. ; Wright Jeremy C., Sustained delivery of leuprolide using an implantable system.
Elkhoury George F. (1561 Ramillo Ave. Long Beach CA 90815) Stein Christoph (310 Warren Ave. ; #302 Baltimore MD 21230), Topical application of opioid analgesic drugs such as morphine.
Gale Robert M. (Los Altos CA) Goetz Victor (Palo Alto CA) Lee Eun S. (Redwood City CA) Taskovich Lina T. (Palo Alto CA) Yum Su I. (Los Altos CA), Transdermal administration of fentanyl and device therefor.
Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, Bing, Devices, formulations, and methods for delivery of multiple beneficial agents.
Poutiatine, Andrew I.; Rampersaud, Charles; Schreck, Thomas; Kolosi, William; Retailleau, Sascha, Drug storage and dispensing devices and systems comprising the same.
DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
Palmer, Pamela; Poutiatine, Andrew I.; Rampersaud, Charles; Edwards, Bruce; Chiu, Edmond; Schreck, Thomas; Tzannis, Stelios; Hamel, Larry, Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms.
Palmer, Pamela; Poutiatine, Andrew I; Rampersaud, Charles; Edwards, Bruce; Chiu, Edmond; Schreck, Thomas; Tzannis, Stelios; Hamel, Larry, Methods for administering small volume oral transmucosal dosage forms using a dispensing device.
Kishawi, Eyad; Imran, Mir A.; Mossop, Brian J.; Kramer, Jeffery M.; O'Connor, Richard W., Selective stimulation systems and signal parameters for medical conditions.
Kishawi, Eyad; Imran, Mir A.; Mossop, Brian J.; Kramer, Jeffery M.; O'Connor, Richard W., Selective stimulation systems and signal parameters for medical conditions.
Palmer, Pamela; Schreck, Thomas; Tzannis, Stelios; Hamel, Larry; Poutiatine, Andrew I., Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain.
Palmer, Pamela; Schreck, Thomas; Tzannis, Stelios; Hamel, Larry; Poutiatine, Andrew I., Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain.
Palmer, Pamela; Schreck, Thomas; Tzannis, Stelios; Hamel, Larry; Poutiatine, Andrew I., Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain.
Poutiatine, Andrew; Edwards, Bruce; Rampersaud, Charles; Palmer, Pamela; Blackwood, Bradley; Yaffe, Benjamin K., Storage and dispensing devices for administration of oral transmucosal dosage forms.
Poutiatine, Andrew; Edwards, Bruce; Rampersaud, Charles; Palmer, Pamela; Blackwood, Bradley; Yaffe, Benjamin K., Storage and dispensing devices for administration of oral transmucosal dosage forms.
Pushpala, Shamim; Hamel, Larry; Tzannis, Stelios; Cruz, Evangeline, Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same.
Gale, Robert M.; Stein, Thomas M.; Audett, Jay; Stepic, Jane; Phipps, Joseph B.; Cormier, Michael J. N., Transdermal analgesic systems with reduced abuse potential.
Gale, Robert M.; Stein, Thomas M.; Audett, Jay; Stepic, Jane; Phipps, Joseph B.; Cormier, Michel J. N., Transdermal analgesic systems with reduced abuse potential.
Lautenbach, Scott C.; De La Serna, Pedro E.; Zamora, Pauline C.; Desjardin, Michael A., Two-piece, internal-channel osmotic delivery system flow modulator.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.